The Ramsay Health Care Limited (ASX: RHC) share price has performed very strongly over the last 12 months, rising by 39.27% from $56.85 to $79.18 (at the time of writing).
In particular it has grown very strongly since mid- September 2019, with Ramsay shares up by 27% since then.
Expansion over the past decade
Ramsay has evolved over the past few decades from a small Australian operation to become Australia’s largest private healthcare provider, with operations in 11 countries including United Kingdom, France, Indonesia, Malaysia and Italy. It is significantly larger than the number two operator in Australia, Healthscope Limited.
Ramsay has consistently grown revenues from its existing facilities, as well as growing through acquisitions and new developments. Its considerable size and scale enables it to spread its operating costs and provides it with a competitive advantage in negotiations with health insurers regarding patient fees.
Ramsay’s overall debt is relatively high, however it appears to be manageable. The ASX healthcare provider has been able to borrow funds relatively easily for new operations, as hospitals are seen as a relatively safe and stable business with a steady flow of patient admissions.
Solid recent financials
For FY19 Ramsay recorded overall revenue of $11.4 billion, a 24.4% increase on the prior corresponding period, boosted by the acquisition of the Capio business. However, if the acquisition is factored out of these results, Ramsay’s revenue grew by only 5.3% on FY18’s result.
The company’s Capio acquisition occurred in 2018, elevating Ramsay to become the second largest private healthcare provider in Europe, with strong positions in both France and Scandinavia.
Ramsay posted a core net profit after tax of $590.9 million in FY19, which was a 2% increase on the prior corresponding period.
Challenges in the private local healthcare system
The healthcare system is highly regulated and changes to government policy with regards to issues such as the healthcare rebate could potentially impact local profits.
In addition, with healthcare premiums becoming unaffordable for an increasing proportion of Australians, this could see more private healthcare patients move towards the public healthcare system.
However, Ramsay’s increasing global diversification should minimise the impact of any such trend.
Ramsay is currently trading at a premium with a price-to-earnings (P/E) ratio of 24.8. However, I don’t think that this is unreasonable for a top quality, established healthcare company with strong positions in its core markets and further room for growth over the next decade.
Healthcare also is a fairly defensive share asset class, as patients are likely to seek hospital treatment regardless of the state of the economy.
However, with such a steep rise in its share price over the last 4 months, Ramsay shares are now beginning to look a bit pricey, especially with the ASX index near all-time highs.
I would therefore probably add Ramsay to your watch list and see if the share price becomes a bit more attractive over the next few months if you are considering purchasing shares.
The post Is it time to buy into this ASX 100 healthcare share? appeared first on Motley Fool Australia.
If you're watching how Ramsay fares over the coming months, here are 3 solid blue-chips to consider for right now.
You’re invited! For a limited time, The Motley Fool Australia is giving away a fantastic FREE report detailing our 3 TOP BLUE CHIP SHARES to buy and own for now and beyond!.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping grossed-up dividend of over 6%! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2020